![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sofosbuvir + Glecaprevir/Pibrentasvir (G/P) in patients with difficult to treat HCV infection. Final results of the French compassionate use
|
|
|
Reported by Jules Levin
DDW 2018 June 2-5 Wash DC  
Victor de Ledinghen, Anne Varaut, Jose Ursic-Bedoya, Lucia Parlati, Jean-Baptiste Hiriart, Giovanna Scoazec, Wassil Merrouche, Georges-Philippe Pageaux, Helene Fontaine, Laurent Alric, Christophe Hezode
![0619181](../images%20/061918/061918-3/0619181.gif)
![0619182](../images%20/061918/061918-3/0619182.gif)
![0619183](../images%20/061918/061918-3/0619183.gif)
![0619184](../images%20/061918/061918-3/0619184.gif)
![0619185](../images%20/061918/061918-3/0619185.gif)
![0619186](../images%20/061918/061918-3/0619186.gif)
![0619187](../images%20/061918/061918-3/0619187.gif)
![0619188](../images%20/061918/061918-3/0619188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|